Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The PART study, a feasibility study comparing radical prostatectomy (RP) and partial ablation (PA) using HIFU of the prostate in men with unilateral, intermediate risk prostate cancer has now completed recruitment.

PART logo

The primary objective of the study was to assess the feasibility of randomising men to a trial of HIFU versus RP with a recruitment target of 80 men. In total, 87 men consented to join the PART study, and 82 of these men went onto be randomised. Patients will be followed up for a total of 3 years as per protocol, with the final follow-up expected to take place in May 2020. The PART research team now plan to submit an application to undertake the main, larger RCT comparing clinical, cost-effectiveness, and quality of life outcomes between radical treatments and PA. 

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Three NIHR HTA grants awarded to Professor Tim Theologis

Congratulations to Professor Tim Theologis, who has been awarded three NIHR HTA grants to extend research in orthopaedic disorders in children.

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.